Call us Today! 561-243-8883
Testing Caption 01 Testing Caption 02 Testing Caption 03 Testing Caption 04 Testing Caption 05 Testing Caption 06

EuroPCR 2014 – The Romanticism of Globalization

By: Giovanni Lauricella Every year in May medical device professionals from all over the world gather in Paris to show off the romanticism of new innovations and development at EuroPCR, at least from a head hunter’s perspective. Companies are rising … More…

abiomed medical

Abiomed and Heartware Merge. The Next Big Play in Heart Failure. A Medical Device Couple That is Likely to Get Hitched.

  By: Joe Mullings First let me say that this is purely my hallucination.  As the heart failure space continues to evolve and the opportunity in the market / patient population starts to move down from the “end stage” heart … More…


NeuroMetrix stock surges on distribution agreement in China

After a long, slow stock slide this year following a February report of lower year-over-year revenue, NeuroMetrix share prices have more than doubled in the past month after the company launched a website, and today announced a new distribution agreement to help … More…


J&J DePuy Synthes Arm Commits More Than $36M To Ramp Up Irish R&D Facility

Johnson & Johnson’s ($JNJ) DePuy Synthes arm plans to spend more than $36 million to build up a research-and-development operation in Ireland. The operation should create 38 research level positions at the company’s plant in Ringaskiddy, and will focus on development work … More…

501k FDA

FDA Asserts Support for Consumer Genetic Tests Despite 23andMe Crackdown

The FDA backs a market that lets consumers easily gain information about their genomes and genetic risks, an agency official said, despite aggressive action that stopped 23andMe from selling its direct-to-consumer health-related genetic tests until they obtain formal regulatory approval. Rather than … More…

input[type="submit"] {display:inherit;}